COHORT STUDY 01 // N=48 EXECUTIVES (AGES 42–58) · ILLUSTRATIVE AGGREGATE
ApoB & Non-HDL Atherogenic Particle Clearance Protocol
Median ApoB 114 mg/dL → 62 mg/dL (-45.6%)
24-Week Quarterly Assay Follow-Up
Lipidologist-Guided Therapy + Viscous Soluble Fiber + Zone-2
Despite 'normal' standard-panel LDL-C readings under 115 mg/dL, baseline NMR subfractionation revealed discordant ApoB particle counts above the 80th percentile. Individualized lipidologist protocols combined with soluble-fiber nutrition and hepatic insulin sensitization lowered median ApoB into the <65 mg/dL longevity target range. Individual clinical outcomes vary.
Build Your Diagnostic Protocol in Configurator →
VERIDIAN CLINIC
Physician-led preventive longevity clinic uniting 112-biomarker blood panels, DunedinPACE epigenetics, radiation-free 3.0T MRI, and VO2 Max physiology. Informational pre-screening only — never submit PHI on public web forms.
DIAGNOSTIC SUITES
112-Biomarker & MRI Panels
Cohort Healthspan Outcomes
Annual Membership Tiers
Membership Configurator
© 2026 VERIDIAN LONGEVITY MEDICAL PC · CLIA / CAP PARTNER ASSAYS · NOT EMERGENCY CARE OR MEDICAL ADVICE
SAN FRANCISCO · NEW YORK · ZURICH · MAX 150 PATIENTS / MD